Brain Cancer
Latest News
Advertisement
Latest Videos
Advertisement
More News
The FDA has recommended the manufacturer of a cell-based immunotherapy terminate a phase 2 clinical trial assessing its effectiveness in recurrent or progressive glioblastoma early and pursue a phase 3 trial which may lead to an approval.
Improving Outcomes for Patients With Brain Metastases
ByPriscilla Brastianos, MD, Massachusetts General Hospital of Harvard Medical School,Manmeet Ahluwalia, MD, Cleveland Clinic,Raymond Sawaya, MD, MD Anderson Cancer Center,Vinai Gondi, MD, Northwestern Medicine Cancer Center,Ralph DeVitto, American Brain Tumor Association (ABTA),Ivy Elkins, Patient,Katie Doble, Patient,Nick Doble, Caregiver
A Caregiver’s Perspective on Treatment Success
ByPriscilla Brastianos, MD, Massachusetts General Hospital of Harvard Medical School,Manmeet Ahluwalia, MD, Cleveland Clinic,Raymond Sawaya, MD, MD Anderson Cancer Center,Vinai Gondi, MD, Northwestern Medicine Cancer Center,Ralph DeVitto, American Brain Tumor Association (ABTA),Ivy Elkins, Patient,Katie Doble, Patient,Nick Doble, Caregiver
Feeling Supported During the Diagnosis and Treatment of Brain Metastases
ByPriscilla Brastianos, MD, Massachusetts General Hospital of Harvard Medical School,Manmeet Ahluwalia, MD, Cleveland Clinic,Raymond Sawaya, MD, MD Anderson Cancer Center,Vinai Gondi, MD, Northwestern Medicine Cancer Center,Ralph DeVitto, American Brain Tumor Association (ABTA),Ivy Elkins, Patient,Katie Doble, Patient,Nick Doble, Caregiver
Effect of Brain Metastasis Treatment on Quality of Life
ByPriscilla Brastianos, MD, Massachusetts General Hospital of Harvard Medical School,Manmeet Ahluwalia, MD, Cleveland Clinic,Raymond Sawaya, MD, MD Anderson Cancer Center,Vinai Gondi, MD, Northwestern Medicine Cancer Center,Ralph DeVitto, American Brain Tumor Association (ABTA),Ivy Elkins, Patient,Katie Doble, Patient,Nick Doble, Caregiver
Individual Assessment of Treatment Success With Brain Metastases
ByPriscilla Brastianos, MD, Massachusetts General Hospital of Harvard Medical School,Manmeet Ahluwalia, MD, Cleveland Clinic,Raymond Sawaya, MD, MD Anderson Cancer Center,Vinai Gondi, MD, Northwestern Medicine Cancer Center,Ralph DeVitto, American Brain Tumor Association (ABTA),Ivy Elkins, Patient,Katie Doble, Patient,Nick Doble, Caregiver
Personal Concerns With Treatment Options for Brain Metastases
ByPriscilla Brastianos, MD, Massachusetts General Hospital of Harvard Medical School,Manmeet Ahluwalia, MD, Cleveland Clinic,Raymond Sawaya, MD, MD Anderson Cancer Center,Vinai Gondi, MD, Northwestern Medicine Cancer Center,Ralph DeVitto, American Brain Tumor Association (ABTA),Ivy Elkins, Patient,Katie Doble, Patient,Nick Doble, Caregiver
Importance of Clinical Trial Enrollment for Patients With Brain Metastases
ByPriscilla Brastianos, MD, Massachusetts General Hospital of Harvard Medical School,Manmeet Ahluwalia, MD, Cleveland Clinic,Raymond Sawaya, MD, MD Anderson Cancer Center,Vinai Gondi, MD, Northwestern Medicine Cancer Center,Ralph DeVitto, American Brain Tumor Association (ABTA),Ivy Elkins, Patient,Katie Doble, Patient,Nick Doble, Caregiver
Factors Considered When Selecting Treatment for Brain Metastases
ByPriscilla Brastianos, MD, Massachusetts General Hospital of Harvard Medical School,Manmeet Ahluwalia, MD, Cleveland Clinic,Raymond Sawaya, MD, MD Anderson Cancer Center,Vinai Gondi, MD, Northwestern Medicine Cancer Center,Ralph DeVitto, American Brain Tumor Association (ABTA),Ivy Elkins, Patient,Katie Doble, Patient,Nick Doble, Caregiver
Systemic Therapies Used for Cancer That Has Spread to the Brain
ByPriscilla Brastianos, MD, Massachusetts General Hospital of Harvard Medical School,Manmeet Ahluwalia, MD, Cleveland Clinic,Raymond Sawaya, MD, MD Anderson Cancer Center,Vinai Gondi, MD, Northwestern Medicine Cancer Center,Ralph DeVitto, American Brain Tumor Association (ABTA),Ivy Elkins, Patient,Katie Doble, Patient,Nick Doble, Caregiver
Role of Radiotherapy and Radiosurgery for Brain Metastases
ByPriscilla Brastianos, MD, Massachusetts General Hospital of Harvard Medical School,Manmeet Ahluwalia, MD, Cleveland Clinic,Raymond Sawaya, MD, MD Anderson Cancer Center,Vinai Gondi, MD, Northwestern Medicine Cancer Center,Ralph DeVitto, American Brain Tumor Association (ABTA),Ivy Elkins, Patient,Katie Doble, Patient,Nick Doble, Caregiver
Discussing Goals of Treatment With Patients and Caregivers
ByPriscilla Brastianos, MD, Massachusetts General Hospital of Harvard Medical School,Manmeet Ahluwalia, MD, Cleveland Clinic,Raymond Sawaya, MD, MD Anderson Cancer Center,Vinai Gondi, MD, Northwestern Medicine Cancer Center,Ralph DeVitto, American Brain Tumor Association (ABTA),Ivy Elkins, Patient,Katie Doble, Patient,Nick Doble, Caregiver
Goals of Treatment for Cancer Which Has Spread to the Brain
ByPriscilla Brastianos, MD, Massachusetts General Hospital of Harvard Medical School,Manmeet Ahluwalia, MD, Cleveland Clinic,Raymond Sawaya, MD, MD Anderson Cancer Center,Vinai Gondi, MD, Northwestern Medicine Cancer Center,Ralph DeVitto, American Brain Tumor Association (ABTA),Ivy Elkins, Patient,Katie Doble, Patient,Nick Doble, Caregiver
The Importance of a Support System During a Diagnosis of Brain Metastases
ByPriscilla Brastianos, MD, Massachusetts General Hospital of Harvard Medical School,Manmeet Ahluwalia, MD, Cleveland Clinic,Raymond Sawaya, MD, MD Anderson Cancer Center,Vinai Gondi, MD, Northwestern Medicine Cancer Center,Ralph DeVitto, American Brain Tumor Association (ABTA),Ivy Elkins, Patient,Katie Doble, Patient,Nick Doble, Caregiver
Experiencing a Diagnosis of Brain Metastases
ByPriscilla Brastianos, MD, Massachusetts General Hospital of Harvard Medical School,Manmeet Ahluwalia, MD, Cleveland Clinic,Raymond Sawaya, MD, MD Anderson Cancer Center,Vinai Gondi, MD, Northwestern Medicine Cancer Center,Ralph DeVitto, American Brain Tumor Association (ABTA),Ivy Elkins, Patient,Katie Doble, Patient,Nick Doble, Caregiver
The Diagnosis of Brain Metastases
ByPriscilla Brastianos, MD, Massachusetts General Hospital of Harvard Medical School,Manmeet Ahluwalia, MD, Cleveland Clinic,Raymond Sawaya, MD, MD Anderson Cancer Center,Vinai Gondi, MD, Northwestern Medicine Cancer Center,Ralph DeVitto, American Brain Tumor Association (ABTA),Ivy Elkins, Patient,Katie Doble, Patient,Nick Doble, Caregiver
The American Brain Tumor Association offers a wealth of online resources for patients with metastatic brain tumors and their loved ones and caregivers.
Importance of the American Brain Tumor Association (ABTA)
ByPriscilla Brastianos, MD, Massachusetts General Hospital of Harvard Medical School,Manmeet Ahluwalia, MD, Cleveland Clinic,Raymond Sawaya, MD, MD Anderson Cancer Center,Vinai Gondi, MD, Northwestern Medicine Cancer Center,Ralph DeVitto, American Brain Tumor Association (ABTA),Ivy Elkins, Patient,Katie Doble, Patient,Nick Doble, Caregiver
Understanding Your Risk for Brain Metastases
ByPriscilla Brastianos, MD, Massachusetts General Hospital of Harvard Medical School,Manmeet Ahluwalia, MD, Cleveland Clinic,Raymond Sawaya, MD, MD Anderson Cancer Center,Vinai Gondi, MD, Northwestern Medicine Cancer Center,Ralph DeVitto, American Brain Tumor Association (ABTA),Ivy Elkins, Patient,Katie Doble, Patient,Nick Doble, Caregiver
Katie’s Journey With Stage IV Ocular Melanoma That Has Spread to the Brain
ByPriscilla Brastianos, MD, Massachusetts General Hospital of Harvard Medical School,Manmeet Ahluwalia, MD, Cleveland Clinic,Raymond Sawaya, MD, MD Anderson Cancer Center,Vinai Gondi, MD, Northwestern Medicine Cancer Center,Ralph DeVitto, American Brain Tumor Association (ABTA),Ivy Elkins, Patient,Katie Doble, Patient,Nick Doble, Caregiver
Ivy’s Journey With Stage IV Non–Small Cell Lung Cancer That Has Spread to the Brain
ByPriscilla Brastianos, MD, Massachusetts General Hospital of Harvard Medical School,Manmeet Ahluwalia, MD, Cleveland Clinic,Raymond Sawaya, MD, MD Anderson Cancer Center,Vinai Gondi, MD, Northwestern Medicine Cancer Center,Ralph DeVitto, American Brain Tumor Association (ABTA),Ivy Elkins, Patient,Katie Doble, Patient,Nick Doble, Caregiver
Discussing the Potential for Brain Metastases With Patients
ByPriscilla Brastianos, MD, Massachusetts General Hospital of Harvard Medical School,Manmeet Ahluwalia, MD, Cleveland Clinic,Raymond Sawaya, MD, MD Anderson Cancer Center,Vinai Gondi, MD, Northwestern Medicine Cancer Center,Ralph DeVitto, American Brain Tumor Association (ABTA),Ivy Elkins, Patient,Katie Doble, Patient,Nick Doble, Caregiver
Cancer Types Associated With Brain Metastases
ByPriscilla Brastianos, MD, Massachusetts General Hospital of Harvard Medical School,Manmeet Ahluwalia, MD, Cleveland Clinic,Raymond Sawaya, MD, MD Anderson Cancer Center,Vinai Gondi, MD, Northwestern Medicine Cancer Center,Ralph DeVitto, American Brain Tumor Association (ABTA),Ivy Elkins, Patient,Katie Doble, Patient,Nick Doble, Caregiver
Researchers try new drug combination to improve overall survival in patients with recurrent high-grade glioma, but are unsuccessful.
The approval of an investigational new drug application will allow Berubicin’s manufacturer to begin studying the investigational drug in adults with glioblastoma who have previously failed their first treatment.
Advertisement
Advertisement
Trending on CURE
1
FDA Accepts Application for Padcev Plus Keytruda For Some With Bladder Cancer
2
Advice for Young Adults Facing Triple-Negative Breast Cancer, Or Any Cancer
3
Alternative Docetaxel Dosing Reduces Toxicity Risk in Prostate Cancer
4
Breast Cancer Awareness Versus ‘It Cannot Be’
5
